.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Squier's Elixirs is stocked at 161 licensed dispensaries across Maine, Massachusetts, and Minnesota, 101 of them in Maine, with the deepest coverage in Portland, South Portland, Eliot, Bangor, and Biddeford. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Beverage holds 63.06% share with 35.75% YoY growth and a 0.61% MoM uptick in July 2026, anchoring Squier's Elixirs while average price fell 11.51% YoY to $25.62. Edible sits at 29.01% share with a −6.33% MoM decline and no YoY read, and Tincture & Sublingual has 7.60% share with a 1,167.11% YoY surge but a −28.73% MoM pullback; Concentrates is 0.33% share with −78.50% YoY and +11.74% MoM. With a 105.77% brand-level YoY sales lift and Beverage at rank 5 in Massachusetts Beverage, the pattern implies Squier's Elixirs is concentrating volume in Beverage while using Tincture & Sublingual as a volatile adjacently expanding channel.
The mix suggests a price-for-volume trade in core Beverage (35.75% YoY growth against a −11.51% YoY price move) combined with opportunistic experimentation in Tincture & Sublingual (1,167.11% YoY balanced by −28.73% MoM), while Edible’s −6.33% MoM signals near-term cannibalization risk from Beverage’s 0.61% MoM. Concentrates’ 0.33% share and −78.50% YoY indicate an exit trajectory despite a +11.74% MoM bounce. Taken together, the shifts imply the brand’s positioning is tilting toward accessible-priced Beverage scale to protect a top-5 footprint while selectively nurturing Tincture & Sublingual for incremental reach rather than diversifying evenly across categories.
Competitive Landscape
Squier's Elixirs sits at rank #5 in MA Beverage in July 2026, improving 1 position from #6 year over year, while also rising 1 spot from #6 over the last three months; this matches its peak rank of #5 in July 2026, indicating a recent ceiling. In contrast, Levia held steady at #1 year over year with sales up 37.16%, and Hi5 Seltzer remained at #2 with 38.24% YoY growth, whereas Pine + Star advanced from #5 to #4 alongside a 26.63% YoY increase; Squier's Elixirs’ single-rank climb contrasts with competitors consolidating or gaining multiple positions, implying its trajectory is upward but capped unless it accelerates beyond incremental share wins.
Notable Products
CBD/CBN/THC 2:1:1 Blackberry Lavender Hash Rosin Gummies 20-Pack (200mg CBD, 100mg CBN, 100mg THC) posted a -36.49% month-over-month drop and slid to rank 4 in July 2026, marking the steepest decline among the top ten and overshadowing the 33.14% gain that lifted THC/THCV 1:1 White Peach & Apricot Hash Rosin Gummies 20-Pack (100mg THC, 100mg THCV) to rank 3. Beverages dominated with five of the top ten SKUs, led by Blueberry Lemon Hash Rosin Elixir Mix (500mg THC, 4oz) at rank 1 with +10.11% MoM and two other Beverage SKUs inside ranks 2 and 6 despite small declines of -1.68% and -1.86%. The mix implies Squier's Elixirs is tilting toward Beverage-led velocity while multi-cannabinoid wellness gummies are rotating out, suggesting near-term assortment pruning in functional Edibles and reinforcement behind fast-moving Elixir flavors.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
